Gsk (GLAXF) Income towards Parent Company (2009 - 2026)

Gsk's Income towards Parent Company history runs 18 years deep, the most recent figure standing at $2.3 billion for Q1 2026.

• In Q1 2026, Income towards Parent Company rose 14.49% year-over-year to $2.3 billion; the TTM figure through Mar 2026 stood at $7.8 billion (up 24.3% YoY), while the FY2025 annual figure was $7.5 billion, up 128.97% from the prior year.
• Income towards Parent Company was $2.3 billion for Q1 2026 at Gsk, up from $846.0 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of $17.5 billion in Q4 2022 to a low of -$75.4 million in Q3 2024.
• Historically, Income towards Parent Company has averaged $3.5 billion across 5 years, with a median of $2.0 billion in 2023.
• The sharpest annual moves came in 2024 and 2025: Income towards Parent Company slumped 104.06% in 2024, then jumped 3704.42% in 2025.
• A 5-year view of Income towards Parent Company shows it stood at $17.5 billion in 2022, then tumbled by 77.97% to $3.9 billion in 2023, then retreated by 26.31% to $2.8 billion in 2024, then plunged by 70.3% to $846.0 million in 2025, then soared by 176.81% to $2.3 billion in 2026.
• The last three Income towards Parent Company figures came in at $2.3 billion (Q1 2026), $846.0 million (Q4 2025), and $2.7 billion (Q3 2025), per Business Quant data.